NCT01979523 2026-03-19Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting42 enrolled 13 charts
NCT01989585 2026-03-19Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaNational Cancer Institute (NCI)Phase 1/2 Active not recruiting75 enrolled